PNC Financial Services Group
SION

PNC Financial Services Group’s Sionna Therapeutics SION Stock Holding History

PNC Financial Services Group’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641 Buy
16
+11
+220% +$420 ﹤0.01% 4857
2025
Q4 		$206 Hold
5
– – ﹤0.01% 4976
2025
Q3 		$147 Buy
+5
New +$109 ﹤0.01% 4966

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group's SION Position: Q1 2026 in Review

PNC Financial Services Group increased its Sionna Therapeutics (SION) stake by 220% in Q1 2026, buying an estimated $420 and bringing the position to 16 shares worth $641. The position accounts for ﹤0.01% of the portfolio, ranked #4857.

PNC Financial Services Group first reported a position in SION in Q3 2025 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • PNC Financial Services Group held 16 shares of Sionna Therapeutics worth $641 as of Q1 2026.
  • PNC Financial Services Group bought 11 Sionna Therapeutics shares in Q1 2026, an estimated $420.
  • Sionna Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4857 holding.
  • PNC Financial Services Group first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.